Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cancer Related Cognitive Decline × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 101 Lung Neoplasms 41 Breast Neoplasms 31 Triple Negative Breast Neoplasms 28 Ovarian Neoplasms 23 Squamous Cell Carcinoma of Head and Neck 21 Small Cell Lung Carcinoma 19 Endometrial Neoplasms 17 Neoplasms 15 Fallopian Tube Neoplasms 15 Head and Neck Neoplasms 13 Uterine Cervical Neoplasms 12 Neoplasm Metastasis 11 Colorectal Neoplasms 10 Carcinoma, Squamous Cell 10 Prostatic Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Esophageal Neoplasms 9 Carcinoma, Transitional Cell 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Recurrence 7 Urinary Bladder Neoplasms 6 Oropharyngeal Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Adenocarcinoma of Lung 5 Stomach Neoplasms 4 Pancreatic Neoplasms 4 Neuroblastoma 4 Mesothelioma 4 Lymphoma, Large B-Cell, Diffuse 4

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡